ACADIA Pharmaceuticals Inc.ACADNASDAQ
Loading
Year-over-year book value per share growth
Percentile
P90
Near historical high
vs 2Y Ago
1.8x
Solid growth
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 33.41% |
| Q3 2025 | 10.87% |
| Q2 2025 | 6.82% |
| Q1 2025 | 4.26% |
| Q4 2024 | 26.53% |
| Q3 2024 | 11.42% |
| Q2 2024 | 10.84% |
| Q1 2024 | 7.49% |
| Q4 2023 | 18.79% |
| Q3 2023 | -8.93% |
| Q2 2023 | 4.98% |
| Q1 2023 | -6.69% |
| Q4 2022 | -6.02% |
| Q3 2022 | -2.23% |
| Q2 2022 | -2.49% |
| Q1 2022 | -17.95% |
| Q4 2021 | -4.72% |
| Q3 2021 | 0.22% |
| Q2 2021 | -3.13% |
| Q1 2021 | -7.67% |
| Q4 2020 | -4.94% |
| Q3 2020 | -2.22% |
| Q2 2020 | 3.08% |
| Q1 2020 | -9.20% |
| Q4 2019 | -4.21% |
| Q3 2019 | 75.30% |
| Q2 2019 | -7.25% |
| Q1 2019 | -20.17% |
| Q4 2018 | 103.63% |
| Q3 2018 | -15.66% |
| Q2 2018 | -13.10% |
| Q1 2018 | -9.72% |
| Q4 2017 | -12.31% |
| Q3 2017 | -9.38% |
| Q2 2017 | -9.61% |
| Q1 2017 | -12.07% |
| Q4 2016 | -13.06% |
| Q3 2016 | 36.36% |
| Q2 2016 | -9.77% |
| Q1 2016 | 102.59% |